Control of NK cell functions by CD4+ CD25+ regulatory T cells

被引:138
作者
Ralainirina, Natacha
Poli, Aurelie
Michel, Tatiana
Poos, Linda
Andres, Emmanuel
Hentges, Francois
Zimmer, Jacques
机构
[1] Ctr Rech Publ Sante, Lab Immunogenet Allergol, L-1526 Luxembourg, Luxembourg
[2] Hop Univ Strasbourg, Serv Med Interne, Clin Med B, Strasbourg, France
关键词
suppression; inhibition; TGF-beta; NKG2D; NATURAL-KILLER-CELL; GROWTH-FACTOR-BETA; DENDRITIC-CELLS; CLOSE ENCOUNTERS; CANCER-PATIENTS; SELF-TOLERANCE; INFECTED-CELLS; TUMOR-CELLS; SUPPRESSION; RECOGNITION;
D O I
10.1189/jlb.0606409
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Regulatory T cells (Treg) are key players in the maintenance of peripheral tolerance. As a result of suppressive effects on CD4(+) and CD8(+) effector T cells, Treg control the adaptive immune system and prevent autoimmunity. In addition, they inhibit B lymphocytes, dendritic cells, and monocytes/macrophages. It is interesting that several recent papers show that CD4(+)CD25(+) Treg are also able to inhibit NK cells. Thus, Treg exert their control on immune responses from the onset (triggering of innate immune cells) to the effector phase of adaptive immunity (B and T cell-mediated responses). That Treg inhibit NK cells suggests that their uncontrolled activation might break self-tolerance and induce "innate" autoimmune pathology. Conversely, Treg-mediated suppression of NK cell functions might have negative effects, as these cells are important in defense against infections and cancer. It is conceivable that Treg might dampen efficient activation of NK cells in these diseases.
引用
收藏
页码:144 / 153
页数:10
相关论文
共 70 条
[1]   IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients [J].
Ahmadzadeh, M ;
Rosenberg, ST .
BLOOD, 2006, 107 (06) :2409-2414
[2]   Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes [J].
Annunziato, F ;
Cosmi, L ;
Liotta, F ;
Lazzeri, E ;
Manetti, R ;
Vanini, V ;
Romagnani, P ;
Maggi, E ;
Romagnani, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :379-387
[3]   Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus [J].
Arnon, TI ;
Achdout, H ;
Levi, O ;
Markel, G ;
Saleh, N ;
Katz, G ;
Gazit, R ;
Gonen-Gross, T ;
Hanna, J ;
Nahari, E ;
Porgador, A ;
Honigman, A ;
Plachter, B ;
Mevorach, D ;
Wolf, DG ;
Mandelboim, O .
NATURE IMMUNOLOGY, 2005, 6 (05) :515-523
[4]  
Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO
[5]  
2-A
[6]   NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions [J].
Assarsson, E ;
Kambayashi, T ;
Schatzle, JD ;
Cramer, SO ;
von Bonin, A ;
Jensen, PE ;
Ljunggren, HG ;
Chambers, BJ .
JOURNAL OF IMMUNOLOGY, 2004, 173 (01) :174-180
[7]  
Azuma T, 2003, CANCER RES, V63, P4516
[8]   Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells [J].
Barao, I ;
Hanash, AM ;
Hallett, W ;
Welniak, LA ;
Sun, K ;
Redelman, D ;
Blazar, BR ;
Levy, RB ;
Murphy, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (14) :5460-5465
[9]   Interleukin-2, interleukin-15, and their roles in human natural killer cells [J].
Becknell, B ;
Caligiuri, MA .
ADVANCES IN IMMUNOLOGY, VOL 86, 2005, 86 :209-239
[10]   Recognition of infected cells by natural killer cells [J].
Carayannopoulos, LN ;
Yokoyama, WM .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (01) :26-33